1
Clinical Trials associated with Neural precursor cells derived from human embryonic stem cell(S Biomedics)A Single Center, Open Label, Single Group, Phase 1/2a Clinical Study to Evaluate the Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC Derived From hESC Line in AIS-A Level of Sub-acute SCI(From 7 to 60 Days)
This study intends to evaluate the safety and exploratory efficacy of transplantation therapy using neural precursor cells (PSA-NCAM(+) NPC) derived from the human embryonic stem cell line for the treatment of paralysis and other related symptoms from sub-acute spinal cord injury.
100 Clinical Results associated with Neural precursor cells derived from human embryonic stem cell(S Biomedics)
100 Translational Medicine associated with Neural precursor cells derived from human embryonic stem cell(S Biomedics)
100 Patents (Medical) associated with Neural precursor cells derived from human embryonic stem cell(S Biomedics)
100 Deals associated with Neural precursor cells derived from human embryonic stem cell(S Biomedics)